Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a report issued on Saturday. The brokerage set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Stock Performance

Shares of STRM opened at $3.68 on Friday. Streamline Health Solutions has a 52-week low of $1.85 and a 52-week high of $9.75. The firm has a market capitalization of $15.72 million, a PE ratio of -0.74 and a beta of 1.67. The firm has a 50-day moving average price of $2.84 and a 200 day moving average price of $5.03. The company has a quick ratio of 0.61, a current ratio of 0.61 and a debt-to-equity ratio of 0.66.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.61) EPS for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.